Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.

Klopfenstein, Timothée; Gendrin, Vincent; Conrozier, Thierry; Gerazime, Aurélie; Puyraveau, Marc; Zayet, Souheil

Klopfenstein, Timothée; Gendrin, Vincent; Conrozier, Thierry; Gerazime, Aurélie; Puyraveau, Marc; Zayet, Souheil.

Afiliación

Klopfenstein T; Infectious Disease Department, North Franche-Comté Hospital, Montbeliard, France timothee.klopfenstein@hnfc.fr.
Gendrin V; Infectious Disease Department, North Franche-Comté Hospital, Montbeliard, France.
Conrozier T; Rheumatology Department, North Franche-Comté Hospital, Montbeliard, France.
Gerazime A; Methodology unit, Clinical Investigation Center INSERM 1431, CHU Besancon, Besancon, France.
Puyraveau M; Methodology unit, Clinical Investigation Center INSERM 1431, CHU Besancon, Besancon, France.
Zayet S; Infectious Disease Department, North Franche-Comté Hospital, Montbeliard, France.

Ann Rheum Dis ; 82(7): e153, 2023 07.

Article en En | MEDLINE | ID: mdl-34162593

Asunto(s)

COVID-19; Humanos; Glucocorticoides/uso terapéutico; Síndrome de Liberación de Citoquinas/tratamiento farmacológico; Tratamiento Farmacológico de COVID-19

Palabras clave

COVID-19; anti-inflammatory agents; antirheumatic agents; non-steroidal

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google